Drug Type Mesenchymal stem cell therapy  | 
Synonyms-  | 
Target-  | 
Action-  | 
Mechanism Stem cell replacements  | 
Therapeutic Areas  | 
Active Indication-  | 
Inactive Indication  | 
Originator Organization  | 
Active Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhaseDiscontinuedPhase 1/2  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| COVID-19 | Phase 2 | Brazil   | 01 May 2022 | 





